Study on the glucocorticoid [corticosteroid]-sparing effects of tocilizumab among glucocorticoid-dependent patients with adult Still's disease and systemic juvenile idiopathic arthritis: the open trial.

Trial Profile

Study on the glucocorticoid [corticosteroid]-sparing effects of tocilizumab among glucocorticoid-dependent patients with adult Still's disease and systemic juvenile idiopathic arthritis: the open trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jul 2013

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Adult-onset Still's disease; Juvenile rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jan 2010 Actual initiation date (Jul 2008) added as reported by University Hospital Medical Information Network - Japan.
    • 15 Jan 2010 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
    • 16 Jul 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top